| P2093 | author name string | Haresh Mani | |
| | Douglas B Stairs | |
| | Thomas J McGarrity | |
| | Atul Bhardwaj | |
| P2860 | cites work | Barrett's esophagus | Q84066457 |
| | Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?" | Q84164037 |
| | Grading of gastric foveolar-type dysplasia in Barrett's esophagus | Q84742768 |
| | A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma | Q84799949 |
| | The problems with surveillance of Barrett's esophagus | Q85087754 |
| | The oesophagus lined with gastric mucous membrane | Q24515052 |
| | Retinoic acid-induced glandular differentiation of the oesophagus. | Q41393923 |
| | New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus | Q41808634 |
| | Dietary patterns and the risk of Barrett's esophagus | Q42032167 |
| | Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium | Q42147313 |
| | Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. | Q42493566 |
| | Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus | Q42504051 |
| | Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK | Q42836024 |
| | Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium | Q42844302 |
| | Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae | Q42872188 |
| | High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy | Q43528543 |
| | An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. | Q43586884 |
| | The histologic spectrum of Barrett's esophagus | Q43675586 |
| | Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans | Q43757853 |
| | Prevalence of Barrett's esophagus in asymptomatic individuals | Q44081495 |
| | Screening for Barrett's esophagus in colonoscopy patients with and without heartburn | Q44184935 |
| | Role of Sonic hedgehog in the development of the trachea and oesophagus | Q44319921 |
| | Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus | Q44680632 |
| | Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus | Q44779979 |
| | Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus | Q45047199 |
| | Trends in incidence of oesophageal and stomach cancer subtypes in Europe. | Q45117256 |
| | Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. | Q45207742 |
| | Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus. | Q45740761 |
| | Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. | Q45960175 |
| | De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 |
| | Surveillance and survival in Barrett's adenocarcinomas: a population-based study | Q46131128 |
| | The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma | Q46151823 |
| | Is Barrett's metaplasia the source of adenocarcinomas of the cardia? | Q46177798 |
| | Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus | Q46504522 |
| | Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial | Q46722081 |
| | Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? | Q47562024 |
| | Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry | Q47811339 |
| | CDX1 is an important molecular mediator of Barrett's metaplasia | Q24529062 |
| | Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas | Q24550868 |
| | Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study | Q24609281 |
| | Durability of radiofrequency ablation in Barrett's esophagus with dysplasia | Q24621075 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus | Q28168285 |
| | Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence | Q28182230 |
| | Prostaglandins and cancer | Q28188827 |
| | Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus | Q28192406 |
| | Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis | Q28194560 |
| | Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence | Q28196944 |
| | Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 |
| | Morphogenesis of the trachea and esophagus: current players and new roles for noggin and Bmps | Q28588087 |
| | Sonic hedgehog is essential to foregut development | Q28591429 |
| | Secular trends in patients diagnosed with Barrett's esophagus | Q30484275 |
| | SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas | Q30491937 |
| | A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data | Q31156910 |
| | Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data | Q31919142 |
| | Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results | Q33187809 |
| | Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus | Q33364676 |
| | Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus | Q33379614 |
| | A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification | Q33387191 |
| | The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia | Q33451132 |
| | Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus | Q33596309 |
| | Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus | Q33611018 |
| | IMproving PArticipation of patients in Clinical Trials--rationale and design of IMPACT | Q33704487 |
| | Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus | Q33905941 |
| | Is there publication bias in the reporting of cancer risk in Barrett's esophagus? | Q33993884 |
| | Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings | Q34037852 |
| | Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 |
| | Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation | Q34238141 |
| | Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study | Q34238147 |
| | The lower esophagus lined by columnar epithelium | Q34241534 |
| | Chronic peptic ulcer of the oesophagus and 'oesophagitis'. | Q34295930 |
| | Phases of biomarker development for early detection of cancer | Q34311577 |
| | The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett | Q34372025 |
| | Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study | Q34471919 |
| | Prevalence of Barrett's esophagus in the general population: an endoscopic study | Q34475247 |
| | Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review | Q34487254 |
| | Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. | Q34504547 |
| | Clinical practice. Barrett's Esophagus | Q34563466 |
| | Experimental Barrett's esophagus and the origin of intestinal metaplasia | Q34569483 |
| | Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis | Q34584800 |
| | Stem cells of the oesophageal epithelium | Q34603090 |
| | Central adiposity and risk of Barrett's esophagus | Q34660127 |
| | Meta analysis: Cancer risk in Barrett's oesophagus. | Q34694561 |
| | Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 |
| | The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis | Q34786281 |
| | CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages | Q34995099 |
| | Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States | Q35114043 |
| | Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma | Q35351828 |
| | Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia | Q35358348 |
| | Mortality in Barrett's oesophagus: results from a population based study | Q35595875 |
| | Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. | Q35613515 |
| | Intestinal metaplasia at the gastroesophageal junction | Q35648638 |
| | American Gastroenterological Association technical review on the management of Barrett's esophagus | Q35673305 |
| | Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? | Q35790574 |
| | Endoscopically observed lower esophageal capillary patterns | Q35937434 |
| | Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study | Q35991301 |
| | Effect of a new diagnosis of Barrett's esophagus on insurance status | Q36060013 |
| | Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis | Q36464443 |
| | Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study | Q36783294 |
| | Low-grade dysplasia in Barrett's esophagus has a high risk of progression | Q36870682 |
| | Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy | Q37015615 |
| | Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. | Q50469967 |
| | Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. | Q50511305 |
| | Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. | Q50535523 |
| | The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. | Q50759399 |
| | Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. | Q50957616 |
| | The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. | Q50980340 |
| | Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. | Q51109115 |
| | Gastric epithelial dysplasia: the Western perspective. | Q51116025 |
| | Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). | Q51213403 |
| | Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis. | Q51559882 |
| | Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. | Q51578892 |
| | Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. | Q51719344 |
| | P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence. | Q51757411 |
| | Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. | Q51762936 |
| | Clinical practice. Barrett's esophagus. | Q51764391 |
| | A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma. | Q52061242 |
| | Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. | Q52858914 |
| | Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. | Q53023140 |
| | Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. | Q53347047 |
| | Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. | Q53358861 |
| | Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. | Q53395845 |
| | An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. | Q53419510 |
| | Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. | Q53548396 |
| | Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. | Q53679889 |
| | Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. | Q53838777 |
| | Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. | Q54111493 |
| | Normal venous circulation of the gastroesophageal junction. A route to understanding varices. | Q54399216 |
| | Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus | Q57259827 |
| | Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study | Q57537923 |
| | Barrett's oesophagus is characterized by a predominantly humoral inflammatory response | Q57939544 |
| | The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria | Q58104636 |
| | Shining light on Barrett’s esophagus | Q58237511 |
| | Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 |
| | Barrett's oesophagus | Q67968848 |
| | Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort | Q68079096 |
| | Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion | Q68687732 |
| | Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis | Q37018235 |
| | Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus | Q37106236 |
| | Vegetable and fruit intakes and risk of Barrett's esophagus in men and women | Q37155234 |
| | Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. | Q37163647 |
| | Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus | Q37176043 |
| | Health-related quality of life in patients with Barrett's esophagus: a systematic review | Q37219940 |
| | Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies | Q37232101 |
| | Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports | Q37234920 |
| | Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus | Q37244793 |
| | Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study | Q37271695 |
| | How to manage a Barrett's esophagus patient with low-grade dysplasia | Q37318426 |
| | Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus | Q37327500 |
| | Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 | Q37330745 |
| | Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis | Q37375062 |
| | Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? | Q37558153 |
| | Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic c | Q37614791 |
| | Endoscopic eradication of Barrett's esophagus | Q37625283 |
| | Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated | Q37749477 |
| | When to consider endoscopic ablation therapy for Barrett's esophagus | Q37763475 |
| | Controversies in the Diagnosis of Barrett Esophagus and Barrett-Related Dysplasia: One Pathologist's Perspective | Q37798020 |
| | Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus | Q37821717 |
| | Still waiting for predictive biomarkers in Barrett's oesophagus. | Q37878719 |
| | Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. | Q38519052 |
| | Effect of antireflux operation on Barrett's mucosa | Q39518064 |
| | Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia | Q39742785 |
| | Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. | Q39997801 |
| | Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. | Q40042187 |
| | Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms | Q40071468 |
| | Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus | Q40752328 |
| | Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells | Q40844993 |
| | Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy | Q41014306 |
| | Endoscopic surveillance of Barrett's esophagus. Does it help? | Q70591962 |
| | Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus | Q70720546 |
| | Histological findings after routine biopsy at the gastro-oesophageal junction | Q73187200 |
| | Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma | Q73455904 |
| | Barrett esophagus--more steps forward | Q73826176 |
| | Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia | Q73933467 |
| | Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus | Q73933469 |
| | Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma | Q73933472 |
| | Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen | Q73934570 |
| | Long-term follow-up of Barrett's high-grade dysplasia | Q74194533 |
| | Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus | Q74564550 |
| | Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria | Q74794748 |
| | The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study | Q77794185 |
| | Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy | Q78296649 |
| | Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus | Q78551320 |
| | Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study | Q79972004 |
| | Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? | Q80240166 |
| | Abdominal obesity and body mass index as risk factors for Barrett's esophagus | Q80611327 |
| | French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus | Q80805524 |
| | Pathophysiology of gastroesophageal reflux disease | Q80950000 |
| | Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus | Q81093852 |
| | Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus | Q81169189 |
| | Abdominal obesity and the risk of Barrett's esophagus | Q81254798 |
| | The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 |
| | Dynamics of the immune reaction to pancreatic cancer from inception to invasion | Q81381605 |
| | The frequency of Barrett's esophagus in high-risk patients with chronic GERD | Q81436315 |
| | Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma | Q81621756 |
| | High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report | Q81808602 |
| | EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus | Q81913673 |
| | Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus | Q82293629 |
| | ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract | Q82971241 |
| | Roles of Kruppel-like factor 4 in oesophageal epithelial cells in Barrett's epithelium development | Q83069703 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| P304 | page(s) | 814146 | |
| P577 | publication date | 2012-05-30 | |
| P1433 | published in | Pathology Research International | Q26853836 |
| P1476 | title | Barrett's Esophagus: Emerging Knowledge and Management Strategies | |
| P478 | volume | 2012 | |